A secondary analysis of the DIPLOMA-2 trial evaluates differences in early physical activity and physiologic stress recovery between patients undergoing minimally invasive vs open ...

Nonrelapse mortality dropped to a single death across 94 transplants, which the authors linked to consistent prophylaxis and supportive care rather than to any new therapy.

In this study, researchers aimed to compare the efficacy of zanidatamab-based combinations against the current standard of care in treatment-naïve, advanced, HER2+ gastric/GEJ cancer.

The index provides additional prognostic separation beyond Memorial Sloan Kettering Cancer Center risk categories and established clinical factors.

This study evaluates public awareness of the link between human papillomavirus (HPV) and cervical cancer and examines the various factors that influence this knowledge among adults in the United ...

Patients diagnosed within three years postpartum do not have significantly worse invasive disease-free survival.

Researchers developed the Advocacy-Adjustment Dyad, a new clinical framework designed to foster therapeutic partnerships between nurses and older adults with cancer in the intensive care unit.

The TROG 08.03 RAVES randomized controlled trial substudy examined quality of life after post-prostatectomy radiation therapy.

To examine the association between vitiligo and skin cancer, researchers compared individuals with a first recorded diagnosis of vitiligo with participants who had a general health care encounter that ...

Early recognition of systemic mastocytosis (SM), coupled with repeat high-sensitivity molecular testing and timely targeted therapy, may substantially alter disease trajectory, even after progression ...

This review evaluates current data on reproductive and hormonal health management for women with TP53 PSVs, highlighting the need for standardized clinical guidance.

This qualitative study examines global approaches to childhood cancer survivorship care to identify common goals and barriers to implementation.